Products | Lamda

Developments Available for Out-Licensing

Molecule	Dosage Form	Strength(s)	Category	System	Status
Acetylcysteine	Capsules	600 mg	Generic	Respiratory	Dossier Ready
Amantadine	Capsules	100 mg	Generic	Nervous	Under Registration
Atomoxetine	Oral Solution	8 mg/mL	Super Generic	Nervous	Under Development
Atropine	Eye drops	1% w/v	Generic	Sensory Organs	Under Registration
Betamethasone	Soluble Tablets	0.5 mg	Generic	Hormone	Marketed
Captopril	Oral Solution	5 mg/mL, 25 mg/5 mL	Super Generic	Cardiovascular	Under Development
Chloral Hydrate	Oral Solution	143 mg/5 ml, 200 mg/5 ml, 500 mg/5 ml	Generic	Nervous	Under Registration
Ciprofloxacin	Solution for Infusion	2 mg/mL	Generic	Anti-infectives	Marketed
Clindamycin	Granules for oral solution	75 mg/5 mL	Generic	Anti-infectives	Under Development
Dexamethasone	Oral Solution	10 mg/5 mL, 20 mg/5 mL	Super Generic	Hormone	Marketed
Dexamethasone	Soluble Tablets	0.5 mg, 2 mg, 4 mg, 8 mg, 10 mg, 20 mg	Super Generic	Hormone	Marketed
Donepezil	Oral Solution	1 mg/mL, 2 mg/mL	Super Generic	Nervous	Marketed
Doxepin	Capsules	25 mg, 50 mg	Generic	Nervous	Marketed
Ethosuximide	Oral Solution	250 mg/5 mL	Generic	Nervous	Marketed
Ethosuximide	Oral Solution	500 mg/5 mL, 750 mg/5 mL	Super Generic	Nervous	Under Development
Flecainide	Oral Solution	25 mg/5 mL	Super Generic	Cardiovascular	Under Registration
Fludrocortisone	Tablets	100 μg	Generic	Hormone	Marketed
Folic Acid	Oral Solution	1 mg/mL	Generic	Blood and Blood Forming Organs	Marketed
Folic Acid	Oral Solution	10 mg/mL	Super Generic	Blood and Blood Forming Organs	Marketed
Gabapentin	Oral Solution	50 mg/mL	Generic	Nervous	Marketed
Glycopyrronium Bromide	Oral Solution	1 mg/5 mL	Super Generic	Alimentary Tract and Metabolism	Marketed
Glycopyrronium Bromide	Tablets	1 mg, 2 mg	Generic	Alimentary Tract and Metabolism	Under Development
Hydrocortisone	Oral Solution	5 mg/5 mL, 10 mg/5 mL	Super Generic	Hormone	Marketed
Hydrocortisone	Soluble Tablets	10 mg, 20 mg	Super Generic	Hormone	Marketed
Isoprenaline	Solution for injection	200 μg/mL	Generic	Cardiovascular	Under Development
Levocarnitine	Oral Solution	300 mg/mL	Generic	Alimentary Tract and Metabolism	Under Registration
Levomepromazine	Tablets	6.25 mg, 25 mg	Generic	Nervous	Under Registration
Levomepromazine	Oral Solution	5 mg/mL	Generic	Nervous	Marketed
Levothyroxine	Oral Solution	25 μg/5 mL, 50 μg/5 mL, 100 μg/5 mL, 125 μg/5 mL	Super Generic	Hormone	Marketed
Levothyroxine	Tablets	25 μg, 50 μg, 75 μg, 100 μg	Generic	Hormone	Under Development
Liothyronine	Capsules	25 μg, 10 μg, 20 μg	Super Generic	Hormone	Marketed
Magnesium Glycerophosphate	Chewable Tablets	4 mmol	Generic	Alimentary Tract and Metabolism	Marketed
Melatonin	Tablets	3 mg	Generic	Nervous	Marketed
Melatonin	Capsules	2 mg, 3 mg, 5 mg	Super Generic	Nervous	Marketed
Melatonin	Oral Solution	1 mg/mL	Super Generic	Nervous	Marketed
Metformin	Oral Solution	500 mg/5 mL, 850 mg/5 mL, 1000 mg/5 mL	Super Generic	Alimentary Tract and Metabolism	Marketed
Mexiletine	Capsules	50 mg, 100 mg, 200 mg	Generic	Cardiovascular	Marketed
Minoxidil	Tablets	2.5 mg, 5 mg, 10 mg	Generic	Cardiovascular	Marketed
Moxifloxacin	Solution for injection	400 mg/250 mL	Generic	Anti-infectives	Marketed
Nortriptyline	Capsules	10 mg, 25 mg	Super Generic	Nervous	Marketed
Nortriptyline	Oral Solution	10 mg/5 mL, 25 mg/5 mL	Super Generic	Nervous	Marketed
Paricalcitol	Solution for Injection	2 μg/mL, 5 μg/mL, 10 μg/2 mL	Generic	Hormone	Marketed
Phenobarbital	Oral Suspension	15 mg/5 mL, 50 mg/5 mL	Super Generic	Nervous	Under Registration
Prednisolone	Oral Solution	10 mg/mL	Super Generic	Hormone	Marketed
Prednisolone	Soluble Tablets	10 mg, 20 mg	Super Generic	Hormone	Under Development
Pregabalin	Oral Solution	20 mg/mL	Generic	Nervous	Marketed
Ranitidine	Oral Solution	150 mg/5 mL	Super Generic	Alimentary Tract and Metabolism	Marketed
Ranitidine	Oral Solution	50 mg/5 mL	Super Generic	Alimentary Tract and Metabolism	Under Development
Sertraline	Oral Suspension	50 mg/5 mL	Super Generic	Nervous	Under Registration
Sodium cromoglicate	Eye Drops	2% w/v	Generic	Sensory Organs	Marketed
Spironolactone	Oral Suspension	25 mg/5mL, 50 mg/5 mL	Super Generic	Cardiovascular	Under Registration
Trazodone	Oral Solution	50 mg/5 mL, 100 mg/5 mL	Super Generic	Nervous	Marketed

Territory/country restrictions may apply. Last update October 2022.